In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vaccibody AS

www.vaccibody.com

Latest From Vaccibody AS

Pipeline Watch: Phase III Starts With VX-445, Reproxalap And AVXS-101

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Pipeline Watch: Phase III Starts With Enzastaurin, Sparsentan And Abaloparatide

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

 

Pipeline Watch Approvals

Venture Funding Deals: Takeda Ups Its Bet On Immuno-Oncology Play Maverick

Biscayne and Japanese CRO SNBL create spin-outs to advance programs; liver disease specialist Ascletis gains funds as it shifts away from HCV; Neon gets $100m to put into its cancer vaccines; and other highlights of recent VC funding.

StartUps and SMEs Financing

Start-Up Previews, November 2012

This Month's Profile Group: Anti-Infective Start-Ups See Opportunity In An Epidemiological Nightmare features profiles of Arasanis, ContraFect and Fedora Pharmaceuticals. Plus these Start-Ups Across Health Care: Arrowhead Medical Technologies, Covagen, Integral Spine Solutions, Maxillent, and Vaccibody.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Norway
  • Parent & Subsidiaries
  • Vaccibody AS
  • Senior Management
  • Martin Bonde, PhD, CEO
    Agnete B Fredriksen, PhD, CSO
    Mona Welschof, PhD, Chief Clinical Officer
  • Contact Info
  • Vaccibody AS
    Phone: 22 95 81 93
    Gaustadalléen 21
    Oslo Research
    Oslo, 0349
    Norway
Advertisement
Advertisement
UsernamePublicRestriction

Register